An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Cited by (690)

Items 601–690 of 690

1. Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis
   Sophie E. Kenny, Fiach Antaw, Warwick J. Locke, Christopher B. Howard, Darren J. Korbie, Matt Trau · 2022 · Life
2. Selection Strategies for Monoclonal Antibodies
   Gerhard Moldenhauer · 2014 · Wiley eBooks
3. Vaccines and Treatment Strategies for SARS-COV-2
   Anasua Sarkar, Ujjwal Maulik · 2020
4. Modulation of the innate immune response by the oncoviruses EBV and HPV
   Peggy Parroche · 2011 · theses.fr (ABES)
5. Immunology of coronavirus disease 2019 raises more questions than answers
   Amre Nasr · 2021 · Saudi Journal for Health Sciences
6. Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain
   Yana O. Romanenko, Marina V. Silkina, Alena S. Kartseva, Maksim A. Marin, Maria A. Shkuratova, Maria A. Makarova, А К Рябко, Daria A. Konyshkova, Natalia A. Zeninskaya, A. E. Khlyntseva et al. · 2023 · Acta Naturae
7. Human monoclonal antibody cloning and expression with overlap extension PCR and short DNA fragments
   Zachary S. Ende, Margarita Mishina, Robert C. Kauffman, Amrita Kumar, RASHMI REKHA KUMARI, Paul R. Knight, Suryaprakash R. Sambhara · 2024 · Journal of Immunological Methods
8. HuAbDiffusion: a discrete language diffusion model used for antibody humanization
   Dongping Liu, Xiaohu Hao, Long Fan · 2025 · Briefings in Bioinformatics
9. Artificial intelligence advancements in monoclonal antibody development technology
   Manar Ammar, Mikhail Yu. Samsonov, Evgeniya Gurylina, Daniel R. Bayzigitov · 2026 · Frontiers in Immunology
10. Humanized Mouse Versus Non-human Primate Models of HIV-1 Infection
    Qingsheng Li, Charles A. Wood · 2014 · Springer eBooks
11. Antibody Engineering as Opportunity for Selection and Optimization of Anti- HIV Therapeutic Agents
    Barbara Frigerio, Silvana Canevari, Mariangela Figini · 2010
12. Involvement of IL-10 in the suppression of antibody production by in vitro immunized peripheral blood mononuclear cells
    Makiko Yamashita, Yoshinori Katakura, Yoshihiro Aiba, Shin‐ei Matsumoto, Kazuko Morihara, Kiichiro Teruya, Akira Ichikawa, Sanetaka Shirahata · 2007 · Cytotechnology
13. COVID-19’da Antikor Bağımlı İmmünpataloji, Monoklonal Antikorlar ve Mutasyonlar
    Bülent Çakal · 2020 · Experimed
14. The Immune System of Mesothelioma Patients: A Window of Opportunity for Novel Immunotherapies
    Fabio Nicolini, Massimiliano Mazza · 2021 · IntechOpen eBooks
15. Orthotopic PDX and CDX Mice Model for Cancer Stem Cell Research
    Jayanta Das, Madhumita Das · 2023 · Handbook of Animal Models and its Uses in Cancer Research
16. Detailed Protocols for the Selection of Antiviral Human Antibodies from Combinatorial Immune Phage Display Libraries
    Philipp Diebolder, Adalbert Krawczyk · 2018 · InTech eBooks
17. The Novel Coronavirus 2019 (COVID-19): A Narrative Review
    Baratali Rezapour, Sayed Jalil Musavi, Faezeh Shirzadeh Maleki · 2020 · International Journal of Coronaviruses
18. Mutations make gut antibodies promiscuous
    Emilie K. Grasset, Andrea Cerutti · 2020 · The Journal of Experimental Medicine
19. Cellular Therapy as Promising Choice of Treatment for COVID-19
    Duygu Koyuncu Irmak, Erdal Karaöz · 2021 · IntechOpen eBooks
20. A Cross-Immunity between SARS-CoV-2 and MERS-CoV: Interest in Anti-SARS-CoV-2 Serotherapy Development Using Dromedary Serum
    Abdeslam Jaafari, Souad Lekchiri, Hafida Zahir, Mostafa Ellouali, Abdallah Badou, Hassan Latrache · 2021 · Infection Epidemiology and Microbiology
21. The Recent Developmental Platforms and Potential Targets of SARS CoV-2 Vaccines: A Comprehensive Review
    Sonam Yangchen Bhutia, Bibhuti Bhusan Kakoti, Prosanta Pal · 2021 · Advances in Pharmacology and Pharmacy
22. Correlation of Clinical Findings with Innate Immunity Against SARS-CoV-2 and Nucleic Acid Expression of SARS-CoV-2 Among Patients in Mongolia
    Ankhbayar Sandagdorj, Naranzul Tsedenbal, Bayasgalan Namuutsetseg, Sarangua Ganbold, Khishigmunkh Chimedregzen, Uuganchimeg Munkhbayar, Gantsooj Baatar, Khurelbaatar Chuluundorj, Darmaa Badarch, Purevbat Bazarjav et al. · 2023 · Infectious Diseases Diagnosis & Treatment
23. Angiotensin-Converting Enzyme 2, the Cellular Receptor for Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
    Wenhui Li, Hyeryun Choe, Michael Farzan · 2014 · ASM Press eBooks
24. Designing Immunity to Hiv: Manipulating Antibody-Dependent Cellular Cytotoxicity Antibodies
    Gamze Isitman, Marjon Navis, Stephen John Kent, Ivan Stratov · 2009 · HIV Therapy
25. How to prepare now for a recurrence of the 1918 influenza epidemic: Storing lymphocytes from 1918 survivors to use as antibody factories
    Eric Lewin Altschuler · 2005 · Medical Hypotheses
26. The History of Therapeutic Monoclonal Antibodies
    Régis Sodoyer · 2016 · Wiley eBooks
27. Discovery of five HIV nucleoside analog reverse-transcriptase inhibitors (NRTIs) as potent inhibitors against the RNA-dependent RNA polymerase (RdRp) of SARS-CoV and 2019-nCoV
    Jialei Sun · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
28. References
    2012 · Elsevier eBooks
29. Identification and Development of Therapeutics for COVID-19.
    Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi et al. · 2021 · PubMed
30. Development of a new genotype–phenotype linked antibody screening system
    Takashi Watanabe, Hikaru Hata, Yoshiki Mochizuki, Fumie Yokoyama, Tomoko Hasegawa, Naveen Kumar, Tomohiro Kurosaki, Osamu Ohara, Hidehiro Fukuyama · 2024 · eLife
31. Development of a diagnostic assay for systemic sclerosis
    Katarzyna N. Pozniak · 2013 · Università Politecnica delle Marche (Università Politecnica delle Marche)
32. Development of Instantaneous Protection against SARS-CoV with Implications for Multiple RNA Viruses
    Hatem A. Elshabrawy · 2012 · Figshare
33. Anti-FR Antibody Generation and Engineering: Development of New Therapeutic Tools
    Silvana Canevari, Mariangela Figini · 2011 · Springer eBooks
34. DNA Damage Response Suppresses Epstein-Barr Virus-Driven Proliferation of Primary Human B Cells
    Pavel A. Nikitin · 2012 · DukeSpace (Duke University)
35. Human Monoclonal Antibodies Against HIV and Emerging Viruses
    Dimiter Stanchev Dimitrov · 2008 · Humana Press eBooks
36. The autoreactive B cell response in myasthenia gravis
    Kathleen Vrolix · 2011
37. Development of techniques for the isolation and characterisation of human monoclonal antibodies from Hepatitis C virus infected individuals
    Victoria Charlotte Edwards · 2012 · Nottingham ePrints (University of Nottingham)
38. Naturally acquired immunity to plasmodium falciparum malaria : antibody responses and immunological memory
    Josea Rono · 2013 · Figshare
39. Characterization of the Plasmodium falciparum antigen VAR4 to identify surface exposed antibody epitopes
    Anja Bengtsson · 2008
40. Therapeutic Antibodies in Multiple Sclerosis
    Norbert Goebels, Burkhard Becher · 2007 · Neurodegenerative Diseases
41. Structure, Immunopathogenesis and Vaccines Against SARS Coronavirus
    Indresh K. Srivastava, Elaine Kan, Isha N. Srivastava, Jimna Cisto, Zohar Biron · 2008 · Springer eBooks
42. Vers l'utilisation des Immunoglobulines A humaines ou de leurs variants à des fins thérapeutiques
    Virginie Pascal · 2009 · OpenGrey (Institut de l'Information Scientifique et Technique)
43. A MICROFLUIDIC PLATFORM FOR SCREENING AND SELECTION OF MONOCLONAL ANTIBODIES FROM SINGLE CELLS
    Anupam Singhal, Daniel DaCosta, Charles A. Haynes, Carl L. Hansen · 2011
44. Development of SARS-COV therapeutics using quaternary protein mimetics
    Tuan Ling Neo · 2009
45. Anti-human platelet antigen (HPA)-1a antibodies: For better or for worse
    Mariana Eksteen · 2015 · NORA - Norwegian Open Research Archives
46. Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand
    Z.-Y. LI, A. YAMASHITA, Norihito Kawashita, Tadahiro Sasaki, Yang Pan, K.-I. ONO, K. IKUTA, Yonggang Li · 2016 · Acta Virologica
47. Immunotherapy and Vaccine Development
    Carol Sze Ki Leung, Christian Münz, Angelika Beate Riemer · 2018 · Journal of Immunology Research
48. Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
    Mira Alt, Jessica Falk, Anna Maria Eis‐Hübinger, Barbara Kropff, Christian Sinzger, Adalbert Krawczyk · 2018 · Journal of Immunological Methods
49. Evaluations Of Severe Acute Respiratory Syndrome Coronavirus Therapeutics And A Viral Capacity For Plasticity And Escape.
    Meagan Bolles · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
50. Severe acute respiratory syndrome (SARS) vaccines
    Bart L. Haagmans, Albert D. M. E. Osterhaus · 2008 · Elsevier eBooks
51. Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens
    Song, Fei · 2014
52. Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors
    Latika Saxena, Madhu Khanna · 2015 · Procedia in Vaccinology
53. Peer Review #1 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"
    2020 · PeerJ
54. Peer Review #2 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.2)"
    2020 · PeerJ
55. Peer Review #2 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"
    2020 · PeerJ
56. Peer Review #3 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"
    2020 · PeerJ
57. COVID-19 y la pandemia global causada por un nuevo coronavirus
    Mario Fernando Benavides-Rosero · 2020 · Universidad y Salud
58. Improvement of in vitro food allergy diagnostics by identifying unique antibody traits
    Anna M. Ehlers · 2021
59. ОСОБЛИВОСТІ ІМУНІТЕТУ ПРИ COVID-19
    Микола Лісяний · 2020 · Immunology and Allergy Science and Practice
60. COVID-19 pandemic: The deadly respiratory disease of 21st century
    Shweta Jain, Pankaj Kumar Jain, Ramakant Yadav, Surendra Jain, Ankur Vaidya · 2021 · Current Research in Pharmaceutical Sciences
61. Convalescent Plasma Immunotherapy - A Possible Mitigation Strategy for SARS-CoV-2 Pandemic
    Rajendran Manikandan, Mithilesh Kumar Singh, Vishal Chander, Gaurav Kumar Sharma, Suresh Bindu, M. Dinesh · 2021 · IntechOpen eBooks
62. COVID-19, a threat to human and animals and its probable treatment options to mitigate this pandemic
    R. K. Patel, A. Agrawal, Aastha Singh, Ashwani Kumar, Jigyasa Rana · 2021 · Journal of Livestock Science
63. A Detailed Scientometric Review of Coronavirus Research
    A. K. Srivastava, Sarika Verma, Medha Mili, Samarendra Maji, Arfat Anis, S. A. R. Hashmi, Kunal Pal · 2022 · Materials horizons
64. Expression of monoclonal antibodies for functional and structural studies
    Vashti Irani, Caroline Soliman, Marcus A. Raftis, Andrew J. Guy, Aaron James Elbourne, Paul A. Ramsland · 2022 · Methods in microbiology
65. Sources of antibody variable chains
    2012 · Elsevier eBooks
66. In Brief
    2004 · Nature reviews. Immunology
67. SARS-CoV-2 infection: Pathogenesis, Immune Responses, Diagnosis
    Kapil Kumar Malviya · 2022 · Journal of Pure and Applied Microbiology
68. Mutational Patterns Observed in SARS-CoV-2 Genomes Sampled From Successive Epochs Delimited by Major Public Health Events in Ontario, Canada: Genomic Surveillance Study
    David Chen, Gurjit S. Randhawa, Maximillian P. M. Soltysiak, Camila PE de Souza, Lila Kari A, Shiva M. Singh, Kathleen Allen Hill · 2022 · JMIR Bioinformatics and Biotechnology
69. Traditional Herbal Medicines: A Prospective Panacea for SARS-CoV-2
    Amul Jain, Apoorva Sharma, Sujata Bais, Simran Kaur, Aastha Verma, Priyank Sinha, Bhanushree Gupta, Veenu Joshi, Rahul Sharma, Amit Dubey et al. · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
70. Passive Immunization
    Mark K. Slifka, Ian J. Amanna · 2023 · Elsevier eBooks
71. Single B-cell sequencing in monoclonal antibody discovery
    Praveen Kumar Neeli, Yong Li · 2023 · Elsevier eBooks
72. Development of a new genotype–phenotype linked antibody screening system
    Takashi Watanabe, Hikaru Hata, Yoshiki Mochizuki, Fumie Yokoyama, Tomoko Hasegawa, Naveen Kumar, Tomohiro Kurosaki, Osamu Ohara, Hidehiro Fukuyama · 2024 · eLife
73. Monoclonal Antibody and Blood Plasma ABO Blood Group Based Therapy Against COVID-19
    Shimuye Kalayu Yirga, Jianda Hu, Minhui Lin · 2022 · Austin Hematology
74. Development of a new genotype–phenotype linked antibody screening system
    Takashi Watanabe, Hikaru Hata, Yoshiki Mochizuki, Fumie Yokoyama, Tomoko Hasegawa, Naveen Kumar, Tomohiro Kurosaki, Osamu Ohara, Hidehiro Fukuyama · 2024 · eLife
75. Development of a new genotype–phenotype linked antibody screening system
    Takashi Watanabe, Hikaru Hata, Yoshiki Mochizuki, Fumie Yokoyama, Tomoko Hasegawa, Naveen Kumar, Tomohiro Kurosaki, Osamu Ohara, Hidehiro Fukuyama · 2024 · eLife
76. Reviewer #1 (Public review): Development of a new genotype–phenotype linked antibody screening system
    2024 · eLife
77. Impact of Synthetic Biology in Point-of-Care Diagnostics
    Sanchao Liu, Alexander J. Winton, Matthew B. Coppock · 2024 · Springer series on chemical sensors and biosensors
78. The Melasterol as Food Supplement with the Purpose of Supporting the Immune System
    Sergio Ferraro, Giulio Tarro · 2025 · British journal of healthcare and medical research
79. Integrating computational and experimental approaches to identify antigen–specific antibodies
    Maria Francesca Abbate, Paul Pereira, Pierre Toxe, Nicolas Maestrali, Marie Gagnaire, Emmanuelle Vigne, Melody A. Shahsavarian, Thierry Mora, Aleksandra M. Walczak · 2026 · Frontiers in Immunology
80. Identification and Characterization of Human Autoreactive T Cells for Autoimmune Research
    Lenka Súkeníková, Daniela Latorre · 2025 · Methods in molecular biology
81. Fungal Vaccines: Recent Trends
    Mohammad Shahid, Abida Malik, Noor Jahan, Hamdan Ibrahim AL-Mohammed, Ali Ibrahim Al‐Sultan, Elsayed Aboulmagd · 2010 · Springer eBooks
82. BCR repertoire analysis and cloning of antibody candidates targeting native and Asp7-isomerized β-amyloid
    Н. А. Николаев, M.Yu. Myshkin, E.A Kolobova, Irina A. Shagina, O.I. Kechko, K. B. Varshavskaya, Ekaterina V. Barsova, T.V. Grigoreva, V.A. Mitkevich, Ekaterina M. Merzlyak et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
83. Nouvelles approches méthodologiques pour l'obtention d'anticorps humains monoclonaux
    Mazhoura Ait Mebarek · 2012 · theses.fr (ABES)
84. Design and Optimization of Recombinant Antibodies Directed Against Platelet Glycoprotein VI with Therapeutic and Diagnostic Potentials
    Muhammad Zahid · 2011 · theses.fr (ABES)
85. Convergent antibody signatures for the measles virus in transgenic rats expressing a human B cell IG repertoire
    Axel Dubois · 2015 · theses.fr (ABES)
86. Etude de marqueurs biologiques prédictifs de la perte de réponse aux anti-TNF
    Mélanie Rinaudo-Gaujous · 2015 · theses.fr (ABES)
87. Characterizing the antibody response at the single cell level with droplet microfluidics
    Carlos Eduardo Castrillon · 2018 · theses.fr (ABES)
88. Rôle des polynucléaires neutrophiles et du FcgRIV dans les effets vaccinaux induit par immunothérapie antivirale par anticorps monoclonaux
    Jennifer Lambour · 2018 · theses.fr (ABES)
89. Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
    Aurélien Sokal · 2022 · theses.fr (ABES)
90. CRISPR/Cas9‐Mediated Gene Knockout Reveals a Nonredundant Role for p16 INK4A in Controlling TCR‐Dependent and Independent CD8 T Cell Expansion
    Silvia Fiori, Cecilia Adragna, Emilia Malvicini, Tommaso Basini, Donatella Galgano, Edoardo Scarpa, Sandra Jovic, Niklas Arndt Schmacke, Veit Hornung, Federica Sallusto et al. · 2026 · European Journal of Immunology